The Substance Use Disorder Long-Acting Injectables: Naltrexone and Buprenorphine is organized by the American Association of Psychiatric Pharmacists. Outline a plan for monitoring and follow up of a patient receiving naltrexone LAI or buprenorphine LAI.
Group items tagged 
